By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics149.5M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States149.5M100.00%